GlyTech, Inc. to Present at the Peptide Therapeutics Symposium (October 25-26, 2018)

GlyTech, Inc. will give an oral presentation entitled “Chemically synthesized glycosylated somatostatin analogs with high metabolic stability and native-like binding affinity to all five receptor subtypes” at the annual Peptide Therapeutics Symposium, held by the Peptide Therapeutics Foundation on October 25th and 26th at the Salk Institute in La Jolla, California, USA.

Last updated:

Back to index of news